抗中性粒细胞胞浆抗体(ANCA)相关血管炎性中耳炎的诊治分析
Otitis Media with Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis(OMAAV):Definition and Early Diagnosis
张志坚;任杰;曹永茂;廖华;杨希林;徐勇;汪雷;王文静;华清泉;
1:武汉大学人民医院耳鼻咽喉头颈外科中心
摘要关键词基金项目(Foundation):作者参考文献1 Kitching AR,Anders HJ,Basu N,et al.ANCA-associated vasculitis[J].Nat Rev Dis Primers,2020,6(1):71.
2 Harabuchi Y,Kishibe K,Tateyama K,et al.Clinical characteristics,the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society[J].Auris Nasus Larynx,2021,48(1):2-14.
3 赵洪军，柴静，左晓霞.以中耳炎反复发作为主要表现的韦格纳肉芽肿病一例[J].中华耳鼻咽喉头颈外科杂志，2012,47(8):683-684.
4 刘玉涛，朱晓宁，仲艳霞.原发性小血管炎首诊耳科2例报告并文献复习[J].山东大学耳鼻喉眼学报，2012,26(6):34-37.
5 邵永良，周永青，李晓明，等.显微镜下多血管炎并分泌性中耳炎误诊原因分析[J].临床误诊误治，2016,29(2):40-44.
6 林丹宇，申宇鹏，李晓明，等.以分泌性中耳炎为首诊症状的ANCA 相关小血管炎的临床误诊2例[J].临床与病理杂志，2018,38(12):2738-2742.
7 郝香月，郑茵，易英，等.以分泌性中耳炎为首发症状的肉芽肿性多血管炎的临床分析[J].听力学及言语疾病杂志，2019,27(4):434-438.
8 Jennette JC,Falk RJ,Bacon PA,et al.2012 revised international chapel hill consensus conference nomenclature of vasculitides[J].Arthritis Rheum,2013,65(1):1-11.
9 冯勃，张延平，韩东一.原发性小血管炎的耳科学表现[J].中华耳科学杂志，2009,7(12):296-299.
10 WierzbickaM,Szyfter W,Puszczewicz M,et al.Otologic symptoms as initial manifestation of wegener granulomatosis:diagnostic dilemma[J].Otol Neurotol,2011,32(6):996-1000.
11 Maranhao AS,Chen VG,Rossini BA,et al.Mastoiditis and facial paralysis as initial manifestations of Wegener’s Granulomatosis[J].Braz J Otorhinolaryngol,2012,78(2):80-86.
12 杨伟炎.恶性肉芽肿、WG与ANCA相关坏死性血管炎[J].中华耳科学杂志，2009,7(6):996-1000.
13 Ntatsaki E,Carruthers D,Chakravarty K,et al.BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis[J].Rheumatology (Oxford),2014,53(12):2306-2309.
14 Yates M,Watts RA,Bajema IM,et al.EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis[J].Ann Rheum Dis,2016,75(9):1583-1594.
15 Nagasaka K,Harigai M,Hagino N,et al.Systematic review and meta-analysis for 2017 clinical practice guidelines of the Japan research committee of the ministry of health,labour,and welfare for intractable vasculitis for the management of ANCA-associated vasculitis[J].Mod Rheumatol,2019,29(1):119-129.
16 Harigai M,Nagasaka K,Amano K,et al.2017 clinical practice guidelines of the Japan research committee of the ministry of health,labour,and welfare for intractable vasculitis for the management of ANCA-associated vasculitis[J].Mod Rheumatol,2019,29(1):20-30.
17 Okada M,Suemori K,Takagi D,et al.The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis[J].Auris Nasus Larynx,2019,46(1):38-42.